MayTech Global Investments »

Tempest Therapeutics shares owned by MayTech Global Investments

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by MayTech Global Investments from 13F filings

Historical chart of MayTech Global Investments investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by MayTech Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by MayTech Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $44k 10k 4.40

More positions owned by MayTech Global Investments

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
MercadoLibre (MELI)
Mastercard Incorporated Cl A (MA)
salesforce (CRM)
Novo-nordisk A S Adr (NVO)
Servicenow (NOW)
Asml Holding N V N Y Registry Shs (ASML)
Dex (DXCM)
Palo Alto Networks (PANW)
Pioneer Natural Resources (PXD)
Intuitive Surgical Com New (ISRG)

View all positions for MayTech Global Investments

Top funds holding Tempest Therapeutics

Vanguard Group
Ikarian Capital
Two Sigma Investments
Citadel Advisors
Simplex Trading
Bank of America Corporation
Two Sigma Securities
Advisor Group Holdings
Virtu Financial
Tocqueville Asset Management
Schonfeld Strategic Advisors
Bank Of Montreal
MayTech Global Investments
Cutler
UBS Group

View all funds holding Tempest Therapeutics